BCRX BioCryst Pharmaceuticals Inc Loading...

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
Time Author Thesis Company / ticker Signal Since call Position Source
15:47
Sep 10
seedy19tron
Buy BCRX because the author explicitly labels it a long idea with $9.25 short-term and $14+.
Buy BCRX because the author explicitly labels it a long idea with $9.25 short-term and $14+ long-term targets, citing Orladeyo durability, cash flow, pipeline value, and strategic interest.
BCRX BioCryst Pharmaceuticals Inc Long — —
13:44
Sep 10
seedy19tron
Added BCRX at $8.20 position
Added to BCRX at $8.20 with capital freed from an MRNA short cover, increasing bullish exposure.
BCRX BioCryst Pharmaceuticals Inc Long — —
23:50
Aug 31
seedy19tron
Hold CCCC BCRX conviction unchanged Portfolio
Maintain long positions in C4 Therapeutics and BioCryst unchanged, consistent with stated conviction in the long book.
BCRX BioCryst Pharmaceuticals Inc Long — —
Log in to see ideas

About BCRX Investor Commentary

Across the available history and selected sources, Buzzberg tracks BCRX (BioCryst Pharmaceuticals Inc) across 3 sources: 19 bullish vs 0 bearish calls from 3 authors. Historical directional balance: 56% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 34 total trade ideas tracked. Latest voices: seedy19tron.